{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:44:18Z","timestamp":1792424658294,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":53,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Patient Saf Surg"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Physicians rely on guidelines derived from randomized controlled trials (RCTs) to determine whether interventions are safe and effective for specific diseases or causal mechanisms. In critical care, however, well-powered RCTs demonstrating clear evidence of benefit and subsequently incorporated into clinical guidelines have repeatedly been abandoned after causing harm. This strong evidence of benefit from robust RCTs or meta-analyses followed by unexpected harm during clinical application, generates an \u201cevidence deployment paradox\u201d, which has been attributed to unavoidable biological heterogeneity rather than to structural flaws in trial design. Recent analysis has shifted attention to the architecture of the RCT itself, indicating that the paradox arises from a mathematical set-mixing problem introduced by a modification of the original RCT model when the field adopted a trial design in which enrollment was decoupled from causal diagnosis or the targeted causal mechanism and replaced by consensus-derived, disease- and cause-agnostic triage thresholds. The triage selects broadly shifting mixtures of diseases with potentially different treatment effects. We term this design the cause-agnostic randomized controlled trial. Although cause-agnostic RCT can generate internally valid estimates within trial participants, their results may paradoxically be unsafe to incorporate into clinical guidelines, even when applied in the same hospitals and using the same entry criteria as the source trials. Structural causal modeling provides tools to mitigate this evidence-deployment paradox. Such modeling makes explicit the causal assumptions underlying enrollment and can identify when, and to what extent, a trial has deviated from cause-and-effect logic of the original randomized trial design.<\/jats:p>","DOI":"10.1186\/s13037-026-00486-y","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T13:37:00Z","timestamp":1776346620000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Inherent safety risks of guidelines derived from \u201ccause-agnostic\u201d randomized controlled trials: a review"],"prefix":"10.1186","volume":"20","author":[{"given":"Lawrence","family":"Lynn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"key":"486_CR1","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13037-025-00388-9","volume":"19","author":"LA Lynn","year":"2025","unstructured":"Lynn LA. Flawed design and selection bias in critical care randomized controlled trials: the patient safety risk of the RCT mimic. Patient Saf Surg. 2025;19:36. https:\/\/doi.org\/10.1186\/s13037-025-00388-9.","journal-title":"Patient Saf Surg"},{"key":"486_CR2","volume-title":"The design of experiments","author":"RA Fisher","year":"1935","unstructured":"Fisher RA. The design of experiments. Edinburgh: Oliver & Boyd; 1935."},{"issue":"4582","key":"486_CR3","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1136\/bmj.2.4582.769","volume":"2","author":"Medical Research Council","year":"1948","unstructured":"Medical Research Council. Streptomycin treatment of pulmonary tuberculosis: a Medical Research Council investigation. BMJ. 1948;2(4582):769\u201382.","journal-title":"BMJ"},{"key":"486_CR4","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1056\/NEJM195207172470301","volume":"247","author":"AB Hill","year":"1952","unstructured":"Hill AB. The clinical trial. N Engl J Med. 1952;247:113\u20139. https:\/\/doi.org\/10.1056\/NEJM195207172470301.","journal-title":"N Engl J Med"},{"key":"486_CR5","doi-asserted-by":"publisher","DOI":"10.1037\/10851-000","volume-title":"Pragmatism: A new name for some old ways of thinking","author":"W James","year":"1907","unstructured":"James W. Pragmatism: A new name for some old ways of thinking. New York: Longmans, Green & Co.; 1907. Lecture VI."},{"key":"486_CR6","unstructured":"University of Colorado School of Medicine, Trauma & Acute Care Surgery. Acute respiratory distress syndrome ventilator protocol: ARDSNet ventilator protocol with FiO\u2082\/PEEP escalation table. NIH ARDS Network ventilator guidance. Available from: https:\/\/medschool.cuanschutz.edu\/docs\/librariesprovider74\/trauma-and-acute-care-surgery-pdfs\/trauma-protocols\/acute-respiratory-distress-syndrome.pdf."},{"key":"486_CR7","doi-asserted-by":"publisher","first-page":"S271","DOI":"10.1513\/AnnalsATS.201704-337OT","volume":"14","author":"AJ Walkey","year":"2017","unstructured":"Walkey AJ, Goligher EC, Del Sorbo L, Hodgson CL, Adhikari NKJ. Low tidal volume versus non-volume-limited strategies for patients with acute respiratory distress syndrome. a systematic review and meta-analysis. Ann Am Thorac Soc. 2017;14:S271\u20139. https:\/\/doi.org\/10.1513\/AnnalsATS.201704-337OT.","journal-title":"Ann Am Thorac Soc"},{"issue":"5","key":"486_CR8","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1007\/s00134-020-06022-5","volume":"46","author":"W Alhazzani","year":"2020","unstructured":"Alhazzani W, M\u00f8ller MH, Arabi YM, et al. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med. 2020;46(5):854\u201387. https:\/\/doi.org\/10.1007\/s00134-020-06022-5.","journal-title":"Intensive Care Med"},{"key":"486_CR9","doi-asserted-by":"publisher","first-page":"e081123","DOI":"10.1136\/bmj-2024-081123","volume":"389","author":"S Hopewell","year":"2025","unstructured":"Hopewell S, Boutron I, Moher D, Altman DG, Schulz KF, CONSORT Group. The CONSORT 2025 statement: updated guidelines for reporting parallel-group randomized trials. BMJ. 2025;389:e081123. https:\/\/doi.org\/10.1136\/bmj-2024-081123.","journal-title":"BMJ"},{"key":"486_CR10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13613-022-01002-9","volume":"12","author":"M Nishikimi","year":"2022","unstructured":"Nishikimi M, Yoshihisa A, Shigematsu K, et al. Mortality of mechanically ventilated patients with COVID-19: a multicenter cohort study. Ann Intensive Care. 2022;12:56. https:\/\/doi.org\/10.1186\/s13613-022-01002-9.","journal-title":"Ann Intensive Care"},{"issue":"1","key":"486_CR11","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1164\/rccm.202006-2405OC","volume":"203","author":"ZJ Lim","year":"2021","unstructured":"Lim ZJ, Subramaniam A, Ponnapa Reddy M, et al. Case fatality rates for patients with COVID-19 requiring invasive mechanical ventilation: a systematic review and meta-analysis. Am J Respir Crit Care Med. 2021;203(1):54\u201366. https:\/\/doi.org\/10.1164\/rccm.202006-2405OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"486_CR12","doi-asserted-by":"publisher","first-page":"227","DOI":"10.4103\/jets.jets_75_21","volume":"14","author":"LA Lynn","year":"2021","unstructured":"Lynn LA, Wheeler E, Woda R, Levitov AB, Stawicki SP, Bahner D. Protocol failure detection: the conflation of acute respiratory distress syndrome, SARS-CoV-2 pneumonia, and respiratory dysfunction. J Emerg Trauma Shock. 2021;14(4):227\u201331. https:\/\/doi.org\/10.4103\/jets.jets_75_21.","journal-title":"J Emerg Trauma Shock"},{"key":"486_CR13","unstructured":"Lynn LA, Leite RO, Lynn DA. The physician\u2019s war: the story of the hidden battle between physicians and a science based on pathological consensus. Amazon; 2024. ISBN: 979-8339212850."},{"issue":"6","key":"486_CR14","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1378\/chest.101.6.1644","volume":"101","author":"RC Bone","year":"1992","unstructured":"Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 1992;101(6):1644\u201355. https:\/\/doi.org\/10.1378\/chest.101.6.1644.","journal-title":"Chest"},{"issue":"9","key":"486_CR15","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1097\/00003246-199809000-00030","volume":"26","author":"National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network","year":"1998","unstructured":"National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Clinical trials in acute respiratory distress syndrome: rationale, design, and organization. Crit Care Med. 1998;26(9):1539\u201346. https:\/\/doi.org\/10.1097\/00003246-199809000-00030.","journal-title":"Crit Care Med"},{"issue":"11","key":"486_CR16","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1513\/AnnalsATS.201605-338OT","volume":"13","author":"AA Ginde","year":"2016","unstructured":"Ginde AA, Moss M, Shapiro NI, et al. The Prevention and Early Treatment of Acute Lung Injury (PETAL) Network: rationale, design, and organization. Ann Am Thorac Soc. 2016;13(11):1856\u201363. https:\/\/doi.org\/10.1513\/AnnalsATS.201605-338OT.","journal-title":"Ann Am Thorac Soc"},{"issue":"13","key":"486_CR17","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1001\/jama.2020.17022","volume":"324","author":"DC Angus","year":"2020","unstructured":"Angus DC, Derde L, Al-Beidh F, Annane D, Arabi Y, Beane A, et al. Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial. JAMA. 2020;324(13):1317\u201329. https:\/\/doi.org\/10.1001\/jama.2020.17022.","journal-title":"JAMA"},{"issue":"7","key":"486_CR18","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1513\/AnnalsATS.202003-192SD","volume":"17","author":"DC Angus","year":"2020","unstructured":"Angus DC, Berry S, Lewis RJ, et al. The REMAP-CAP study: rationale and design of a randomized embedded multifactorial adaptive platform trial for community-acquired pneumonia. Ann Am Thorac Soc. 2020;17(7):879\u201391. https:\/\/doi.org\/10.1513\/AnnalsATS.202003-192SD.","journal-title":"Ann Am Thorac Soc"},{"issue":"2","key":"486_CR19","doi-asserted-by":"publisher","first-page":"e269","DOI":"10.1097\/CCM.0000000000006564","volume":"53","author":"TML Almeida","year":"2025","unstructured":"Almeida TML, Cavalcanti AB, Zampieri FG, Freitas FGR, Pontes LCP, Azevedo LCP, et al. Acetylsalicylic acid treatment in patients with sepsis and septic shock: a randomized, double-blind, placebo-controlled phase 2 trial. Crit Care Med. 2025;53(2):e269\u201381. https:\/\/doi.org\/10.1097\/CCM.0000000000006564.","journal-title":"Crit Care Med"},{"issue":"10","key":"486_CR20","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1056\/NEJM200103083441001","volume":"344","author":"GR Bernard","year":"2001","unstructured":"Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, PROWESS Study Group, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344(10):699\u2013709. https:\/\/doi.org\/10.1056\/NEJM200103083441001.","journal-title":"N Engl J Med"},{"issue":"22","key":"486_CR21","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1056\/NEJMoa1202290","volume":"366","author":"VM Ranieri","year":"2012","unstructured":"Ranieri VM, Thompson BT, Barie PS, Dhainaut JF, Douglas IS, Finfer S, PROWESS-SHOCK Study Group, et al. Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med. 2012;366(22):2055\u201364. https:\/\/doi.org\/10.1056\/NEJMoa1202290.","journal-title":"N Engl J Med"},{"issue":"12","key":"486_CR22","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1056\/NEJMoa1005372","volume":"363","author":"L Papazian","year":"2010","unstructured":"Papazian L, Forel JM, Gacouin A, Penot-Ragon C, Perrin G, Loundou A, et al. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med. 2010;363(12):1107\u201316. https:\/\/doi.org\/10.1056\/NEJMoa1005372.","journal-title":"N Engl J Med"},{"issue":"21","key":"486_CR23","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1056\/NEJMoa1901686","volume":"380","author":"M Moss","year":"2019","unstructured":"Moss M, Huang DT, Brower RG, Ferguson ND, Ginde AA, Gong MN, ROSE Investigators; NHLBI PETAL Clinical Trials Network, et al. Early neuromuscular blockade in the acute respiratory distress syndrome. N Engl J Med. 2019;380(21):1997\u20132008. https:\/\/doi.org\/10.1056\/NEJMoa1901686.","journal-title":"N Engl J Med"},{"issue":"7","key":"486_CR24","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1001\/jama.2019.0071","volume":"321","author":"G Hern\u00e1ndez","year":"2019","unstructured":"Hern\u00e1ndez G, Ospina-Tasc\u00f3n GA, Damiani LP, Estenssoro E, Dubin A, Hurtado J, et al. Effect of a resuscitation strategy targeting peripheral perfusion status vs serum lactate levels on 28-day mortality among patients with septic shock. JAMA. 2019;321(7):654\u201364. https:\/\/doi.org\/10.1001\/jama.2019.0071.","journal-title":"JAMA"},{"issue":"4","key":"486_CR25","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1056\/NEJMoa032193","volume":"351","author":"RG Brower","year":"2004","unstructured":"Brower RG, Lanken PN, MacIntyre N, Matthay MA, Morris A, Ancukiewicz M, NHLBI ARDS Clinical Trials Network, et al. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med. 2004;351(4):327\u201336. https:\/\/doi.org\/10.1056\/NEJMoa032193.","journal-title":"N Engl J Med"},{"issue":"6","key":"486_CR26","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1001\/jama.299.6.637","volume":"299","author":"MO Meade","year":"2008","unstructured":"Meade MO, Cook DJ, Guyatt GH, Slutsky AS, Arabi YM, Cooper DJ, et al. Lung Open Ventilation Study Investigators. Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome. JAMA. 2008;299(6):637\u201345. https:\/\/doi.org\/10.1001\/jama.299.6.637.","journal-title":"JAMA"},{"issue":"6","key":"486_CR27","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1001\/jama.299.6.646","volume":"299","author":"A Mercat","year":"2008","unstructured":"Mercat A, Richard JC, Vielle B, Jaber S, Osman D, Diehl JL, et al. Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA. 2008;299(6):646\u201355. https:\/\/doi.org\/10.1001\/jama.299.6.646.","journal-title":"JAMA"},{"issue":"18","key":"486_CR28","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1056\/NEJM200005043421801","volume":"342","author":"ARDS Network Investigators","year":"2000","unstructured":"ARDS Network Investigators. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342(18):1301\u20138. https:\/\/doi.org\/10.1056\/NEJM200005043421801.","journal-title":"N Engl J Med"},{"issue":"23","key":"486_CR29","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1056\/NEJMoa1214103","volume":"368","author":"C Gu\u00e9rin","year":"2013","unstructured":"Gu\u00e9rin C, Reignier J, Richard JC, Beuret P, Gacouin A, Boulain T, PROSEVA Study Group, et al. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med. 2013;368(23):2159\u201368. https:\/\/doi.org\/10.1056\/NEJMoa1214103.","journal-title":"N Engl J Med"},{"key":"486_CR30","unstructured":"Hern\u00e1n MA, Robins JM. Causal inference: what if. Boca Raton (FL): Chapman & Hall\/CRC; 2020. Available from: https:\/\/www.hsph.harvard.edu\/miguel-hernan\/causal-inference-book\/."},{"key":"486_CR31","unstructured":"Pearl J, Mackenzie D. The book of why: the new science of cause and effect. New York: Basic Books; 2018. ISBN: 978-0465097609."},{"issue":"1","key":"486_CR32","doi-asserted-by":"publisher","first-page":"24","DOI":"10.36401\/JQSH-23-X2","volume":"6","author":"SMM El-Awady","year":"2023","unstructured":"El-Awady SMM. Overview of Failure Mode and Effects Analysis (FMEA): a patient safety tool. Glob J Qual Saf Healthc. 2023;6(1):24\u20136. https:\/\/doi.org\/10.36401\/JQSH-23-X2.","journal-title":"Glob J Qual Saf Healthc"},{"issue":"1","key":"486_CR33","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3390\/healthcare13010082","volume":"13","author":"M Vecchia","year":"2025","unstructured":"Vecchia M, Sacchi P, Marvulli LN, Salio F. Healthcare application of Failure Mode and Effect Analysis (FMEA): prospective risk analysis and mitigation. Healthc (Basel). 2025;13(1):82. https:\/\/doi.org\/10.3390\/healthcare13010082.","journal-title":"Healthc (Basel)"},{"key":"486_CR34","doi-asserted-by":"publisher","unstructured":"De Cassai A, et al. Responsible use of large language models in manuscript authorship, peer review, and editorial processes: a Delphi consensus among editors-in-chief of anaesthesia and pain medicine journals (RULE-AP). Br J Anaesth. 2026 (Feb 25; online ahead of print) https:\/\/doi.org\/10.1016\/j.bja.2026.01.029. PMID: 41748337.","DOI":"10.1016\/j.bja.2026.01.029"}],"container-title":["Patient Safety in Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13037-026-00486-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13037-026-00486-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13037-026-00486-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:13:05Z","timestamp":1781647985000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13037-026-00486-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["486"],"URL":"https:\/\/doi.org\/10.1186\/s13037-026-00486-y","relation":{},"ISSN":["1754-9493"],"issn-type":[{"value":"1754-9493","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]},"assertion":[{"value":"30 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This manuscript relied on the use of Large Language Models (Chat GPT, 2026) for preparation of the tables, the appendix, glossary and editing of the manuscript. The author declares to retain the ultimate responsibility for the accuracy, integrity, and originality of the content of this manuscript, in compliance the 2026 RULE-AP consensus paper [\n                      \n                      ].","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure on the use of LLM\/AI tools"}},{"value":"Dr. Lynn owns Lyntek Medical Technologies, a research and development company in Columbus, Ohio, USA, which designs software for analysis of electronic medical records data designed for protocol failure mode detection.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22"}}